Innovair® (Asthma)

Innovair® is indicated in the regular treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate:

• patients not adequately controlled with inhaled corticosteroids and "as needed" inhaled short-acting beta2-agonist or
• patients already adequately controlled on both inhaled corticosteroids and long-acting beta2-agonists.

Innovair® is not appropriate for treatment of acute asthma attacks.